Moore KA - Search Results

1

Development and deployment of COVID-19 vaccines for those most vulnerable.

Koff WC, Schenkelberg T, Williams T, Baric RS, McDermott A, Cameron CM, Cameron MJ, Friemann MB, Neumann G, Kawaoka Y, Kelvin AA, Ross TM, Schultz-Cherry S, Mastro TD, Priddy FH, Moore KA, Ostrowsky JT, Osterholm MT, Goudsmit J. Koff WC, et al. Among authors: moore ka. Sci Transl Med. 2021 Feb 3;13(579):eabd1525. doi: 10.1126/scitranslmed.abd1525. Sci Transl Med. 2021. PMID: 33536277 Review.

2

Meningococcal disease and public health practice: a complicated road map.

Moore KA, Osterholm MT. Moore KA, et al. JAMA. 1998 Feb 11;279(6):472-3. doi: 10.1001/jama.279.6.472. JAMA. 1998. PMID: 9466643 No abstract available.

3

A statewide survey of immunization rates in Minnesota school age children: implications for targeted assessment and prevention strategies.

Ehresmann KR, White KE, Hedberg CW, Anderson E, Korlath JA, Moore KA, Osterholm MT. Ehresmann KR, et al. Among authors: moore ka. Pediatr Infect Dis J. 1998 Aug;17(8):711-6. doi: 10.1097/00006454-199808000-00010. Pediatr Infect Dis J. 1998. PMID: 9726346

4

Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.

Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, Johnson BP, Moore KA, Osterholm MT. Smith KE, et al. Among authors: moore ka. N Engl J Med. 1999 May 20;340(20):1525-32. doi: 10.1056/NEJM199905203402001. N Engl J Med. 1999. PMID: 10332013 Free article.

5

Addressing emerging infections. The partnership between public health and primary care physicians.

Danila RN, Lexau C, Lynfield R, Moore KA, Osterholm MT. Danila RN, et al. Among authors: moore ka. Postgrad Med. 1999 Aug;106(2):90-2, 97-8, 103-5. doi: 10.3810/pgm.1999.08.642. Postgrad Med. 1999. PMID: 10456042 Review.

6

Public health in the age of ebola in West Africa.

Osterholm MT, Moore KA, Gostin LO. Osterholm MT, et al. Among authors: moore ka. JAMA Intern Med. 2015 Jan;175(1):7-8. doi: 10.1001/jamainternmed.2014.6235. JAMA Intern Med. 2015. PMID: 25317856 No abstract available.

7

The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats.

Osterholm M, Moore K, Ostrowsky J, Kimball-Baker K, Farrar J; Wellcome Trust-CIDRAP Ebola Vaccine Team B. Osterholm M, et al. Lancet Infect Dis. 2016 Jan;16(1):e1-e9. doi: 10.1016/S1473-3099(15)00416-8. Epub 2015 Oct 30. Lancet Infect Dis. 2016. PMID: 26526664 Free PMC article. Review.

8

Chronic Wasting Disease in Cervids: Implications for Prion Transmission to Humans and Other Animal Species.

Osterholm MT, Anderson CJ, Zabel MD, Scheftel JM, Moore KA, Appleby BS. Osterholm MT, et al. Among authors: moore ka. mBio. 2019 Jul 23;10(4):e01091-19. doi: 10.1128/mBio.01091-19. mBio. 2019. PMID: 31337719 Free PMC article.

9

Tracking progress in universal influenza vaccine development.

Ostrowsky J, Arpey M, Moore K, Osterholm M, Friede M, Gordon J, Higgins D, Molto-Lopez J, Seals J, Bresee J. Ostrowsky J, et al. Curr Opin Virol. 2020 Feb;40:28-36. doi: 10.1016/j.coviro.2020.02.003. Epub 2020 Apr 9. Curr Opin Virol. 2020. PMID: 32279026 Review.

10

Influenza response planning for the centers of excellence for influenza research and surveillance: Science preparedness for enhancing global health security.

Moore KA, Ostrowsky JT, Mehr AJ, Osterholm MT; CEIRS Pandemic Planning Committee. Moore KA, et al. Influenza Other Respir Viruses. 2020 Jul;14(4):444-451. doi: 10.1111/irv.12742. Epub 2020 Apr 19. Influenza Other Respir Viruses. 2020. PMID: 32306541 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

393 results

Search Page